Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.

@article{Goodale2009FlowCA,
  title={Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.},
  author={David W Goodale and Carolina Phay and W. Kent Brown and Leslie A Gray-Statchuk and Patricia A Furlong and Michael D Lock and Ian H. Chin-Yee and Michael Keeney and Alison L Allan},
  journal={Cytometry. Part B, Clinical cytometry},
  year={2009},
  volume={76 2},
  pages={107-17}
}
BACKGROUND Monocyte activation in cancer patients may be reflective of anticancer activity. However, studies indicate that recruitment of macrophages can actually promote tumor growth and angiogenesis. Assessment of other microenvironmental cells such as circulating endothelial cells (CECs) may provide additional information regarding disease progression. The objective of this study was to assess monocyte activation and CECs in breast cancer patients and determine the potential clinical… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Interleukin-17A modulates circulating tumor cells in tumor draining vein of colorectal cancers and affects metastases.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…